Abstract-Blood pressure responses to lycorenine were investigated in rats and dogs. Lycorenine (10-40 mg/kg p.o.) produced a decrease in blood pressure in conscious rats which was greater in hypertensive rats than in normotensive rats. In conscious dogs, lycorenine (5 or 10 mg/kg i.v.) produced rises in blood pressure and heart rate except for a few instances, while it produced a decrease in blood pressure in pentobarbital anesthetized dogs. Thus, there are species differences in cardiovascular effects of lycorenine between conscious rats and dogs. The development of tachyphylaxis to the vasodepressor actions of lycorenine and its related compounds was related to their alpha-adrenergic blocking activities at the time of the second injection in anesthetized rats. Desipramine which abolished or diminished the development of tachyphylaxis to the vasodepressor action of lycorenine (5 or 7.5 mg/kg i.v.), shortened the duration of its vasoderessor action and reduced its alpha-adrenergic blocking action. These results indicate that the development of tachyphylaxis to the vasodepressor action of lycorenine is ascribed to maintenance of its alpha-adrenergic blocking action.
Lycorenine, a component of Lycoris radiata Herb., produces decreases in blood pressure and heart rate, and marked tachyphylaxis to both responses develops with repeated injections of lycorenine in pentobarbital anesthetized rats (1) . It was shown in a preceding paper (1) that the vaso-depressor action of lycorenine may be attributed to the alpha-adrenergic blockade in conjunction with reduction in the spontaneous sympathetic nerve activity and that the bradycardia induced by lycorenine may be produced by activation of the vagus.
The alpha-adrenergic blocking activity of lycorenine has been demonstrated by its inhibitory effects on the pressor responses induced by stimulation of the segment of the sympathetic outflow from the spinal cord and by the i.v. administration of noradrenaline in rats, and on the noradrenaline-induced contraction of the mouse seminal vesicles (1) . In the present work, the anti-hypertensive effects of lycorenine were investigated in conscious, hypertensive rats, and the effects of lycorenine on blood pressure and heart rate were investigated in anesthetized or conscious dogs.
It has been speculated (1) that the development of tachyphylaxis to a decrease in blood pressure with repeated injections of lycorenine may be at least in part ascribed to the duration of its alpha-adrenergic blocking action. With respect to this speculation, we investigated the effects of repeated injections of lycorenine and its related compounds on blood pressure and the duration of their alpha-adrenergic blocking actions, and the effects of desipramine on the development of tachyphylaxis to and the duration of the vasodepressor action of lycorenine and its alpha-adrenergic blocking action.
MATERIALS AND METHODS
Male Donryu rats, weighing 250-300 g and mongrel dogs of either sex, weighing 8-15 kg were used.
Rats were anesthetized with sodium pentobarbital 70 mg/kg, i.p. and dogs with sodium pentobarbital 35 mg/kg, i.v. Blood pressure was recorded from the femoral artery on a polygraph (Nihon Kohden RM-150) by means of a pressure transducer (Nihon Kohden RP-3). Heart rate was monitored with a tachometer (Nihon Kohden RT-2) triggered by blood pressure pulse. In a conscious state, blood pressure was directly measured using the procedure similar to that described by Weeks and Jones (2) for rats and using that described by Saxena (3) for dogs. In rats, an arterial cannula (polyethylene tubing, PE 10) was inserted into the aorta through the puncture which was made with 22 gauge needle when occluding the aorta with the tip of a finger, and a venous cannula (PE 10) was put into the vena cava through the femoral vein. In dogs, an arterial cannula (Polyethylene tubing, PE 50) was Renal hypertensive rats were produced by clamping the left renal artery with a silver clip with an aperture of 0.3 min and contralateral nephrectomy. Adrenal regeneration hypertensive rats were produced by bilateral enucleation of the adrenal glands followed by treatment with 1 % NaC1 aqueous solution as drinking water.
Drugs: Lycorenine was extracted and purified from Lycoris radiata Herb. and lycorenine related compounds were prepared in our laboratory. Other drugs used were desipramine hydrochloride (Pertofran,® Fujisawa), noradrenaline bitartrate (Wako), and d-tubocurarine chloride (Tokyo Kasei). Lycorenine and its related compounds were dissolved in dilute HCl solution and this solution was neutralized with 1N-NaOH. Other compounds were dissolved in saline. Drug doses refer to the salts except for lycorenine and its related compounds which were expressed in terms of the base. All drugs were given i.v. unless otherwise mentioned. In conscious dogs, drugs were given i.v. at the rate of 3 ml/kg body weight/3 min. The significance of difference between two means was evaluated using Student's t-test. Effect of lycorenine on blood pressure and heart rate in dogs: Lycorenine (5 mg/kg) produced marked decreases in blood pressure and heart rate in pentobarbital anesthetized dogs (Fig. 2) , while increases in blood pressure and heart rate were seen in 5 out of 7 conscious dogs with the dose of 5 mg/kg and in 6 out of 8 conscious dogs with the dose of 10 mg/kg (Fig. 3) , and decreases in blood pressure and heart rate in the remaining two conscious dogs at each dose. Thus, the effect of lycorenine on blood pressure in conscious dogs differed from that in anesthetized dogs. In conscious dogs, lycorenine produced tremor, respiratory stimulation, salivation, defecation, restlessness, and motor incoordination with the dose of 10 mg/kg. These behavioral changes were manifested a few minutes after i. ( Fig. 4) , marked tachyphylaxis to the vasodepressor actions developed with repeated in jections of lycorenine and compound 2 at 30 min intervals, while in other lycorenine related compounds, the vasodepressor actions at the second injection did not significantly differ from those seen with the first injection in anesthetized rats (Table 1) was not influenced by bilateral vagotomy in anesthetized rats (Table 2 ). In bilaterally vago tornized, anesthetized rats, the development of tachyphylaxis to the vasodepressor action of lycorenine (5 mg/kg) was completely abolished by treatment with despiramine (1 mg/kg) 5 min before the first or second injection of lycorenine (Table 2 ). In normal anesthetized rats, pretreatment with despiramine (1 mg/kg) reduced but did not abolish the development of tachyphylaxis to the vasodepressor action of lycorenine (7.5 mg/kg) ( Table 2 ). Pretreat ment with desipramine shortened the duration of the vasodepressor response to 5 or 7.5 mg/ kg of lycorenine, in bilaterally vagotomized or normal anesthetized rats, respectively (Fig. 6) .
Pretreatment with desipramine (1 mg/kg) significantly shortened the duration of the inhibitory activity of lycorenine (5 mg/kg) on the vasopressor response induced by i.v. admin istration of noradrenaline in anesthetized rats (Fig. 7) and reduced the inhibitory activity of lycorenine (7.5 mg/kg) on the vasopressor response induced by stimulation of the sympa thetic outflow from the spinal cord in pithed rats (Fig. 5) . 
DISCUSSION
We have suggested (1) that lycorenine may produce in anesthetized rats a vasodilatation by the blockade of the sympathetic vasoconstrictor tone.
In the present experiments, lycorenine also produced a vasodepressor action in conscious normotensive rats and an even more marked response in conscious hypertensive rats.
On the other hand, lycorenine produced increases in blood pressure and heart rate in conscious dogs, except for a few instances, while this drug produced marked decreases in blood pressure and heart rate, in anesthetized dogs. Thus, there are species differences in cardiovascular effects of lycorenine between conscious rats and dogs. Such phenomena were seen in the case of yohimbine (5-7). It has been reported that yohimbine shows a decrease in blood pressure in both anesthetized and conscious rats, when given i.v., while this drug produces a decrease in blood pressure in anesthetized dogs, but an increase in blood pressure in conscious dogs. The vasopressor action of yohimbine in conscious dogs is reported to be mediated through central mechanisms (6) and its vasodepressor action is apparently due to depressant action on the vasomotor center (8) and peripheral alpha-adrenergic blockade. Cardiovascular effects of lycorenine may thus resemble those of yohimbine in many aspects including the mechanism of the vasodepressor response. However, there are differences between the effects of these two drugs.
Yohimbine produces increases in blood pressure and heart rate with intracerebroventricular injection in both anesthetized and conscious rats (7), while lycorenine does not produce cardiovascular effects when given intracerebroventricularly, except in large doses in anesthetized rats (1) . In conscious dogs, lycorenine produced a distinct stimulation of the central nervous system as characterized by cholinergic symptoms.
Kaul et al. (9) found that N-propynyl dibenzazepine (PDA), an alpha-adrenergic blocking agent, produced similar behavioral changes in conscious dogs and suggested that PDA produced an alpha-adrenergic blockade in the central nervous system, thus leading to an autonomic imbalance in favor of the parasympathetic component, and that such would explain the cholinergic symptoms. It was also reported that the activity of the vagus is normally depressed by central noradrenergic neurons (10) . Thus, lycorenine may produce cholinergic symptoms following an alpha-adrenergic blockade in the central nervous system.
In addition, as lycorenine induced cholinergic activities with isolated guinea-pig ileum (unpublished) at higher concentrations (1-4 x 10-5 -/ml), such a peripheral effect might also be involved in the above mentioned behavioral changes.
It was proposed in our preceding paper (1) depressor action, and reduced its alpha-adrenergic blocking action at the time of the second injection of lycorenine, at 30 min intervals. These phenomena can be explained on the basis of the enhancing action of desipramine on the concentration of available catecholamines in the vicinity of alpha-adrenergic receptors, and such is attributed to its blocking action on uptake of catecholamines into sympathetic nerve endings. Thus, these effects of desipramine also support the above mentioned hypothesis. Consequently, lycorenine may produce only a small decrease in blood pressure with the second injection, because at that time the alpha-adrenergic blocking action of lycorenine is still maintained, although the blood pressure levels have returned to initial ones, presumably by recovery from the reduction of the sympathetic nerve activity (1) and autoregulatory vasoconstrictor reactions (11) .
In anesthetized dogs, we found no clear evidence for the development of tachyphylaxis to the vasodepressor action of lycorenine (5 mg/kg), as tachyphylaxis to the vasodepressor action did not always develop with repeated injection of lycorenine at 90 min intervals and such is required for the return of blood pressure to its initial level.
